Happy Head Named Best Personalized Minoxidil Provider for Women

NEW YORK, Sept. 7, 2026 /CourierPR/ -- Happy Head, a telehealth provider of personalized hair-loss treatments, has been named the 2026 choice for women seeking customized minoxidil formulas by Consumer365. The designation highlights Happy Head’s ability to adapt prescription hair care solutions based on individual patient needs, including age, medical history, hair loss pattern, and preferred delivery method.

The company’s personalized approach involves more than 200 possible formulations, from topical preparations with up to 8% minoxidil to oral regimens that may include minoxidil with other prescription ingredients. Patients can complete a remote assessment, after which a board-certified dermatologist reviews their health information and, when medically appropriate, issues a prescription.

Each compounded formula is made fresh per order and delivered directly to the patient’s home, ensuring a tailored experience. Happy Head also offers dermatology support for formula adjustments based on tolerance and response. The company’s co-founders, board-certified dermatologists Dr. Ben Behnam and Dr. Sean Behnam, have over 15 years of experience in hair restoration clinics, combining clinical expertise with breakthrough science to deliver personalized solutions.

Happy Head categorizes its women’s prescription products into age-based groups, reflecting the importance of individualized care. For women 50 and older, the company offers the TopicalRx SuperSolution ProBlend™, a scalp-applied formula with 8% minoxidil and several other active ingredients. The TopicalRx Solution + SuperCapsule™ pairs a topical solution with a capsule containing oral minoxidil, dutasteride, and vitamin D3. The SuperCapsule™: Dutasteride, Minoxidil & Vitamin D3 is an oral prescription formula for this age group.

For women under 50, the options include the TopicalRx Solution: Minoxidil + Retinoic Acid™, applied directly to the scalp, and Spironolactone, an oral prescription option that is not a form of minoxidil. These categories describe the intended age groups, not automatic eligibility. Happy Head also cautions that finasteride and dutasteride are not recommended for women who are planning pregnancy, pregnant, or breastfeeding.

Topical and oral minoxidil differ in their delivery routes and potential side effects. Topical minoxidil is applied directly to the scalp, while oral minoxidil is swallowed and has systemic effects. Happy Head’s compounded topical formulas may include retinoic acid, dutasteride, finasteride, or other ingredients when prescribed. Oral plans may place minoxidil in one capsule with other medicines or use a non-minoxidil drug such as spironolactone.

The telehealth process begins with an online assessment reviewed by a board-certified dermatologist. If a prescription is approved, a customized monthly treatment is prepared and shipped without an in-person office visit. Many patients may see visible regrowth within three to six months of consistent use, though individual timelines and outcomes vary, and no result is guaranteed. Formula changes may be made under dermatologist supervision when needed.

Happy Head’s personalized approach to hair loss treatment stands out in the industry, offering compounded medications that are not FDA-approved and may be prescribed off-label. The company emphasizes that treatment suitability and results vary, and a licensed healthcare provider must determine whether a treatment is appropriate.